SCHEMBL6894474

SCHEMBL6894474

Cc1c(N2CCC(O)(CC(=O)O)CC2)nc2c(-c3ccn(C)c3)cnn2c1N

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.35
KDM4E B2RXH2 10/20 0.35
RAB9A P51151 9/20 0.35
SMN1; SMN2 Q16637 6/20 0.35
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
CASP3 P42574 3/20 0.34
SENP8 Q96LD8 3/20 0.34
SENP7 Q9BQF6 3/20 0.34
SENP6 Q9GZR1 3/20 0.34
HSD17B10 Q99714 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 4/20 0.34
TP53 P04637 4/20 0.34
NFKB1 P19838 1/20 0.34
STAT1 P42224 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
KDR P35968 3/20 0.33
RET P07949 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894464 0.90 CHEK1 (0.40) NPC1KDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL6893177 0.83 PDE2A (0.37) NPC1KDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL10237277 0.79 CHEK1 (0.52) RETCHEK1CCNA2CDK2CCNA1
SCHEMBL6893154 0.73 CHEK1 (0.44) NPC1KDM4ERAB9ASMN1; SMN2HSD17B10
SCHEMBL6894139 0.72 FASN (0.38) NPC1KDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL10234363 0.69 CHEK1 (0.43) NPC1KDM4ERAB9AMEN1KMT2A
SCHEMBL6893236 0.67 CHEK1 (0.52) RETCHEK1CCNA2CDK2CCNA1
SCHEMBL6893164 0.67 CHEK1 (0.46) NPC1KDM4ERAB9ASMN1; SMN2MEN1
SCHEMBL10234160 0.66 CCNC (0.40) RETCHEK1CCNA2CDK2CCNA1
SCHEMBL6893234 0.66 CHEK1 (0.52) RETCHEK1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed
US-20110054013-A1 TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS MERCK SHARP & DOHME CORP. 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110054013-A1 TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS BACE1, BACE2, PSEN1 NPC1 1172/4885KDM4E 3091/4885RAB9A 2744/4885
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MTOR, RICTOR, RPTOR NPC1 348/4885KDM4E 1448/4885RAB9A 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.